SG11201507215VA - Use of specific carbohydrate systems during pregnancy for improving bone development and formation and/or for improving cognitive and cns development in offspring - Google Patents

Use of specific carbohydrate systems during pregnancy for improving bone development and formation and/or for improving cognitive and cns development in offspring

Info

Publication number
SG11201507215VA
SG11201507215VA SG11201507215VA SG11201507215VA SG11201507215VA SG 11201507215V A SG11201507215V A SG 11201507215VA SG 11201507215V A SG11201507215V A SG 11201507215VA SG 11201507215V A SG11201507215V A SG 11201507215VA SG 11201507215V A SG11201507215V A SG 11201507215VA
Authority
SG
Singapore
Prior art keywords
development
improving
offspring
formation
during pregnancy
Prior art date
Application number
SG11201507215VA
Inventor
José María López Pedrosa
Manuel Cristóbal Manzano Martín
María-Jesús Martín Martín
Elena Oliveros Delgado
Ricardo Rueda Cabrera
María Del Pilar Bueno Vargas
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of SG11201507215VA publication Critical patent/SG11201507215VA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
    • A23L29/206—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
    • A23L29/212—Starch; Modified starch; Starch derivatives, e.g. esters or ethers
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
    • A23L29/206—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
    • A23L29/262—Cellulose; Derivatives thereof, e.g. ethers
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A23L33/22—Comminuted fibrous parts of plants, e.g. bagasse or pulp
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7016—Disaccharides, e.g. lactose, lactulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/718—Starch or degraded starch, e.g. amylose, amylopectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
SG11201507215VA 2013-03-15 2014-03-12 Use of specific carbohydrate systems during pregnancy for improving bone development and formation and/or for improving cognitive and cns development in offspring SG11201507215VA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP13382088.6A EP2777403A1 (en) 2013-03-15 2013-03-15 Use of specific carbohydrate systems during pregnancy for improving bone development and formation and/or for improving cognitive and cns development in offspring
PCT/US2014/023971 WO2014150687A1 (en) 2013-03-15 2014-03-12 Use of specific carbohydrate systems during pregnancy for improving bone development and formation and/or for improving cognitive and cns development in offspring

Publications (1)

Publication Number Publication Date
SG11201507215VA true SG11201507215VA (en) 2015-10-29

Family

ID=47997321

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201507215VA SG11201507215VA (en) 2013-03-15 2014-03-12 Use of specific carbohydrate systems during pregnancy for improving bone development and formation and/or for improving cognitive and cns development in offspring

Country Status (10)

Country Link
US (1) US20160030466A1 (en)
EP (1) EP2777403A1 (en)
CN (1) CN105392375A (en)
BR (1) BR112015023487A2 (en)
CA (1) CA2904157A1 (en)
HK (1) HK1201422A1 (en)
IL (1) IL241007A0 (en)
PH (1) PH12015502132A1 (en)
SG (1) SG11201507215VA (en)
WO (1) WO2014150687A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2022010647A (en) * 2020-02-27 2022-09-23 Abbott Lab Methods of improving bone health.

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6989166B2 (en) * 2001-12-20 2006-01-24 N.V. Nutricia Soft drink replacer
US6884445B2 (en) * 2001-12-20 2005-04-26 N.V. Nutricia Matrix-forming composition containing pectin
AU2012261503B2 (en) * 2005-04-06 2014-10-30 Société des Produits Nestlé S.A. A method and composition for nutritionally improving glucose control and insulin action
EP2211629B1 (en) * 2007-10-19 2020-07-08 Fonterra Co-Operative Group Limited Methods of maintaining or increasing growth or cognitive development
WO2009153064A2 (en) * 2008-06-19 2009-12-23 N.V. Nutricia Liquid nutritional composition for bariatric surgery patients
WO2012074375A1 (en) * 2010-12-01 2012-06-07 N.V. Nutricia Prevention or treatment of overweight and obesity in type 2 diabetic patients
EP2502507A1 (en) * 2011-03-21 2012-09-26 Abbott Laboratories Methods for improving bone health in infants using prebiotics

Also Published As

Publication number Publication date
EP2777403A1 (en) 2014-09-17
HK1201422A1 (en) 2015-09-04
PH12015502132A1 (en) 2016-01-25
CA2904157A1 (en) 2014-09-25
BR112015023487A2 (en) 2017-07-18
WO2014150687A1 (en) 2014-09-25
US20160030466A1 (en) 2016-02-04
IL241007A0 (en) 2015-11-30
CN105392375A (en) 2016-03-09

Similar Documents

Publication Publication Date Title
HK1221053A1 (en) Method and system for maintaining or improving wellness
ZA201601250B (en) Density enhancement methods and compositions
SG11201604906QA (en) Cloud-based transactions methods and systems
EP2945678A4 (en) Patient interface and method for making same
EP2945680A4 (en) Patient interface and method for making same
GB201317458D0 (en) Improved pregnancy test device and method
HK1204073A1 (en) Human body security inspection method and system
IL264559A (en) Methods and reagents for the assessment of gestational diabetes
HK1225938A1 (en) Methods and systems for determining breast density
GB201309880D0 (en) Methods and apparatus for performing local transactions
SG11201510325XA (en) Methods for promoting neuronal development and/or health
GB201312776D0 (en) Data integration and cleansing
EP2968309A4 (en) Use of levocetirizine and montelukast in the treatment of vasculitis
SG11201507637UA (en) Tissue closure device and method
EP2943913A4 (en) System and method for reducing data transmission volume in tomosynthesis
ZA201504763B (en) Surgical template arrangement and method
EP2964165A4 (en) Uterine compression devices and methods
IL233535A0 (en) Use of specific carbohydrate systems during pregnancy for effecting the offspring
PL2999478T3 (en) Dextran sulfate for use in mobilization of cells
ZA201602129B (en) Audiometry system and method
HK1221913A1 (en) Use of par-1 antagonists for preventing and/or treating pelvi- perineal functional pathological conditions par-1 /-
ZA201508813B (en) System and method for facilitating transactions
SG10201801906QA (en) Swap crossing system and method
IL241007A0 (en) Use of specific carbohydrate systems during pregnancy for improving bone development and formation and/or for improving cognitive and cns development in offspring
IL246199A0 (en) Tampon and method for making the same